Medical Doctor Program year 2021 Source: CMS Open Payments, 2026 publication

Elias Granadillo Deluque

Neurology Madison, WI Medical Doctor

NPI 1477865574 CMS profile 747311

600 Highland Ave, Madison, WI 53792

Open in the dashboard

General payments

$257

1 record reported · program year 2021

Research payments

$222

Paid to them · 1 record reported · program year 2021

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$462,040 paid to institutions, not to them · program years 2019–2025

Through program year 2021, Elias Granadillo Deluque of Madison, WI is reported in the CMS Open Payments database as having received $257 across 1 general payment and $222 in research payments paid to them. Separately, studies naming them as principal investigator received $462,040 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 35th percentile of Neurology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2021 General $257 1
2021 Research $222 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Elias Granadillo Deluque
  • Neurology median
  • Middle half of Neurology
  • National median

In program year 2025, general payments to Elias Granadillo Deluque were reported at $0. Among 11,022 Neurology profiles paid that year, the median was $457 and the middle half received between $118 and $2,344.

Show as a table
Year Elias Granadillo Deluque Neurology median Middle half National median
2019 $0 $474 $118–$2,177 $163
2020 $0 $367 $82–$2,309 $114
2021 $257 $438 $104–$2,547 $132
2022 $0 $442 $103–$2,388 $149
2023 $0 $464 $119–$2,312 $160
2024 $0 $468 $119–$2,323 $164
2025 $0 $457 $118–$2,344 $169

Breakdown

Who paid General payments · program year 2021
  1. Becton, Dickinson and Company $257 1 payment

Every payment, record by record

What the payments were for General payments · program year 2021
  1. Consulting Fee $257 1 payment
Research payments came from Research payments · program year 2021
  1. Eli Lilly and Company $222 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 12 drugs

Part D claims

1,349

Median for Neurology: 833

Drug cost

$29,781

Median for Neurology: $202,670

Branded share of claims

2.1%

Median for Neurology: 25.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Memantine Hcl Generic 445 $15,377
Donepezil Hcl Generic 664 $6,380
Rivastigmine Generic 34 $4,367
Memantine Hcl Er Memantine Hcl Brand 15 $1,054
Sertraline Hcl Generic 82 $651
Rivastigmine Rivastigmine Tartrate Brand 14 $531
Risperidone Generic 13 $435
Venlafaxine Hcl Generic 18 $414
Quetiapine Fumarate Generic 18 $256
Mirtazapine Generic 12 $226

The 10 drugs with the highest cost, of 12 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 13,695 Part D prescribers listed as Neurology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 8 billing codes

Paid by Medicare

$32,586

Medicare's payments for the services billed

Medicare patients

261

Average age 75

Services billed

354

135 women, 126 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 72%
Alzheimer's or dementia 50%
Arthritis 45%
Depression 34%
Ischemic heart disease 33%
Diabetes 26%
Chronic kidney disease 26%
Heart failure 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

2 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurology in Wisconsin

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2021

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record